Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea · Delayed Price · Currency is KRW 1,384.00
+14.00 (1.02%)
Aug 12, 2026, 3:30 PM KST
Xcell Therapeutics Market Cap
Xcell Therapeutics has a market cap or net worth of 23.69 billion as of August 11, 2026. Its market cap has decreased by -36.48% in one year.
Market Cap
23.69B
Enterprise Value
22.67B
Revenue
2.64B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,384.00
ChartMarket Cap Chart
Since July 15, 2024, Xcell Therapeutics's market cap has decreased from 90.22B to 23.69B, a decrease of -73.74%. That is a compound annual growth rate of -47.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 23.69B | -17.52% |
| Dec 30, 2025 | 28.73B | -35.28% |
| Dec 30, 2024 | 44.38B | -50.80% |
| Jul 15, 2024 | 90.22B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vaxcell-Bio Therapeutics | 96.98B |
| MedPacto | 94.94B |
| iNtRON Biotechnology | 80.78B |
| Prestige BioPharma | 79.33B |
| CG Invites | 76.43B |
| Amicogen | 72.14B |
| ENCell | 68.05B |
| ORIENT BIO | 63.14B |